Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy - Wikidata - wikimedia - TriplyDB

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

http://www.wikidata.org/entity/Q34857119

about

Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis Immune regulation of bone metastasis Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients Engineering long shelf life multi-layer biologically active surfaces on microfluidic devices for point of care applications The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Predictive Value of Preoperative Neutrophil Lymphocyte Ratio in Determining the Stage of Gastric Tumor.Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.Elevated preoperative neutrophil-to-lymphocyte ratio can predict poor survival in early stage gastric cancer patients receiving radical gastrectomy: The Fujian prospective investigation of cancer (FIESTA) study.Prognostic value of PLR in various cancers: a meta-analysis.The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer Prognostic value of neutrophil to lymphocyte ratio for gastric cancer.Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer.Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer.The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation.Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer.Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer.The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer.Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study.A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer.Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.Elevated neutrophil to lymphocyte ratio predicts mortality in medical inpatients with multiple chronic conditions.Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma.Pretreatment neutrophil-to-lymphocyte ratio and its dynamic changes are associated with the overall survival in advanced cancer patients undergoing palliative care Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma.Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection.Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer Blood mean platelet volume and platelet lymphocyte ratio as new predictors of hip osteoarthritis severity.

P2860

Q26765926-32C05498-7F1B-4FAB-A90B-354CC5915ECA Q27005871-18E9412E-8002-4F56-8CF1-422162DC4CA5 Q27009534-BC4CBBCC-5BB1-4E30-8D00-F6F133F65CED Q30390401-C799AEEC-CCF6-4C14-93AF-FAA08637317A Q33613591-6B123030-707F-4318-8588-36BDF00C3327 Q33627306-CDB466C5-78B8-43C7-A511-0636F94A96FE Q33714143-E31250C2-A9B4-4A92-8FAA-F2CFB81F7792 Q33762053-3A0EFE65-9BA5-4CDF-BD54-28BEF2A0EB19 Q33776722-B04F5450-F099-4FB4-9027-AD698CF4145B Q33812584-5EB76024-B4A7-4E76-9B03-121794F5C81A Q33994372-3486BB32-2A50-4C8B-9266-E924C65E135F Q34337667-C6699AF3-F5B0-425C-A75B-D95FE75674B9 Q35151707-E04AD948-B201-4999-9AA3-16AD7673DF91 Q35152328-E010AB11-DF6B-4402-A5BF-9F5AEE710F0E Q35238082-DA299895-053F-446B-AF4B-F94D59A3AF1F Q35424504-68BDF87A-F336-4C46-8660-66C0BCD5FC2F Q35595696-01846D63-3E13-438C-88EC-1CA89BE86087 Q35608987-7A19BFAF-ACF2-4D82-9DC0-C88207F7CAFF Q35651537-9AB7515F-6E9C-4879-8210-2E69AD23B16A Q35766555-489E45BA-781E-4113-9D41-2D6267D4BE16 Q35783836-E22C9EEE-2F49-4161-9F59-F4B45B69448A Q35936092-B8D62AAD-22C9-417F-B55C-C56653EE0D35 Q35956259-60B21CB9-F63C-4F74-A052-8DE6633A09B8 Q36195847-5B88D33E-EE24-4597-A9A7-FBE38DC92FB2 Q36216141-F0139431-D1DD-4B6A-B9F3-BB269F076248 Q36283286-ACC3E789-67A5-4D5D-AA42-4715586ED5CA Q36338120-B00B5B3C-43DC-4918-B0C5-5847B1759EF9 Q36562386-D5686E3A-9F23-46C0-9223-5F05BBA0DBCB Q36631514-F0EE2F6E-4104-47AB-8546-01DFB021D73C Q36640764-BC980424-ADA1-463A-963E-19079F662B4B Q36825610-881D73B7-6872-4E1F-99A5-D5EC135F3F7F Q36967771-39C67294-170E-422F-8385-008ACFA77489 Q37003669-EED993C3-DADB-4C38-802E-8A4AC0D0FE9A Q37035451-D9C66B2F-2A59-4B55-82DF-A870B9081C8F Q37129614-7304B805-9D8D-4ED0-B008-4130B9F2D133 Q37166986-E56A72C3-A793-49C5-B1FB-8BA65D1EE91B Q37354169-FA8E5CA3-0CA4-4798-801B-2623942882B6 Q37536826-A964AC4D-6489-4ABC-B22C-CFB845F7C735 Q37580326-2A3D3760-B811-440F-9467-23BEE1CBA006 Q37646712-CFFBFF35-F4C5-442C-8CBB-D6B0E00DDB2F

P2860

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

http://www.wikidata.org/entity/Q34857119

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@ast

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@en

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@nl

type

label

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@ast

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@en

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@nl

prefLabel

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@ast

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@en

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@nl

P1433

Q34857119-B3F223B7-47E2-4E59-A665-41F26F4CBE7E

P1476

Q34857119-462221A7-4D1C-4409-AA20-52E7A1314750

P2093

Q34857119-040B9F76-5DFF-40C5-970B-280762F2ADE8

Q34857119-22E2D5E4-A5F9-43F9-8B3C-F2701F18287B

Q34857119-3F3DE1C9-7676-49D6-9F47-CCFEA529B9B0

Q34857119-970748F8-3268-4B2B-9B50-946D743AA3E2

Q34857119-DDCE453A-0FA8-4294-8535-3F02A5A5F474

Q34857119-E6F3001B-4DA7-4B25-A352-9D1F0E94D576

Q34857119-EF4DDFAA-7EB0-4F5F-87E8-43343A55F931

P2860

Q34857119-0DDF25BB-50F0-4A11-BD4E-5DCB4C923292

Q34857119-15FBD9A6-3BDD-4711-82CC-0B3A60E14A59

Q34857119-1758210C-DF8E-4150-98AF-F3971B766BF7

Q34857119-1E1E9296-0AEF-4AAA-8C36-6EE471012C27

Q34857119-1F1F1F38-5705-49CB-99C4-521AD1DC1901

Q34857119-222AE5EA-8202-4EE0-8A8F-3DC75691A15B

Q34857119-25883FB6-070C-411E-984A-AAC34F4C942B

Q34857119-38954A92-C4BB-490B-A110-113915864F55

Q34857119-4FAAE50E-84F0-4302-821F-08CCB6629DC5

Q34857119-55352836-BB3D-4180-BBD6-B0816815E021

P2888

Q34857119-47DBE79F-F9AF-4967-B978-147257818C9B

P304

Q34857119-4E09E465-4FE7-47F8-9C9F-EC534CF23ED0

P31

Q34857119-116B7E3A-ED24-448E-8733-E54CD2D52582

P356

Q34857119-3B7E50A7-7375-47B5-A20B-839DA74E594D

P407

Q34857119-1B3A85D8-5835-457D-837B-8851ACD8EF6C

P478

Q34857119-22EABEAD-647E-4E0E-BE78-42BBD621EE2C

P577

Q34857119-A32D1B7F-ED7F-4CF7-AAE9-D96074EB201F

P5875

Q34857119-5F090017-9351-4120-B24C-D15566CDA148

P6179

Q34857119-7F48B9E1-C996-4FDA-B96D-68068660F630

P698

Q34857119-CE965FFB-87DE-484A-A00F-6BE4B63D9FBE

P921

Q34857119-00917E84-070D-4C0D-99B7-B47FA36D2D25

Q34857119-06BDD7A4-EC97-492A-829A-0F69064737C6

Q34857119-2735B308-E5EB-4744-B5C6-EE08A0968A63

P932

Q34857119-DB770A3C-1A63-4884-BB29-9DF928741C83

P356

1471-2407-13-350

P1433

P1476

Prognostic significance of neu ...... eated with FOLFOX chemotherapy

@en

P2093

Hyo-Jin Kim

http://www.w3.org/2001/XMLSchema#string

Ji Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Ki Han Kim

http://www.w3.org/2001/XMLSchema#string

Min Chan Kim

http://www.w3.org/2001/XMLSchema#string

Suee Lee

http://www.w3.org/2001/XMLSchema#string

Sung Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Sung Yong Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Global cancer statistics, 2002

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer

Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer

The role of chemotherapy in metastatic gastric cancer.

Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.

Platelets and angiogenesis in malignancy.

High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

P2888

1471-2407-13-350

P304

350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-350

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

251233839

http://www.w3.org/2001/XMLSchema#string

P6179

1013932022

http://www.w3.org/2001/XMLSchema#string

P698

23876227

http://www.w3.org/2001/XMLSchema#string

P921

P932

3729814

http://www.w3.org/2001/XMLSchema#string